Navigation Links
Positive Results Published Using AtriCure Minimally Invasive Products
Date:1/7/2008

ward-looking statement, and actual results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE AtriCure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
4. BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
5. DURECT Announces Positive ELADUR(TM) Phase IIa Study Results
6. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
7. Chroma Announces Positive Phase I Efficacy Data for Novel Cancer Therapy CHR-2797
8. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
9. Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
10. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...re/ -- S*BIO Pte Ltd today announced the initiatio...t and orally-active JAK2 inhibitor, in leading med...c idiopathic myelofibrosis (CIMF). , , The...rability of SB1518 in patients with CIMF and is ex...rt of the study will assess the safety profile and...
(Date:12/1/2008)...ox1 gene is a two-way switch that, if turned off, ...med so that they lose their identity and become mo..., Tenn., Dec. 1 Scient... discovered that a certain differentiated cell typ...res the constant expression of a gene called Prox...
(Date:12/1/2008)...ember 1 Following a,Req...o procure an MVA-based,third generation smallpox...nada, on behalf of the Canadian Department of Nati...Nordic for the delivery of IMVAMUNE(R). , T...as part of the,country,s bio-preparedness program...
(Date:12/1/2008)...re-FirstCall/ -- Vical Incorporated (Nasdaq: VIC...milestone payment from Merck & Co., Inc. based...al trial of an investigational plasmid DNA (pDNA) ...Vical,s DNA gene delivery technology and encodes h...RT is the subject of separate license agreement. ,...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation 969 1CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation 969 2Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference 491 1CellCyte Genetics Corp Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue 240 1CellCyte Genetics Corp Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue 240 2CellCyte Genetics Corp Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue 240 3CellCyte Genetics Corp Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue 240 4Study shows insurance status not race linked to complications in patients with acute appendicitis 962 1Study shows insurance status not race linked to complications in patients with acute appendicitis 962 2
(Date:12/1/2008)...PICK: Harnessing miRNA natural gene repressors for...eagues, at Memorial Sloan-Kettering Cancer Center,...te the expression of genes for therapeutic purpose...herapy in mice. , Small, noncoding RNA molecules...f gene expression. In the study, the miRNA miR-181...
(Date:12/1/2008)...r Chooses Two Tampa Beneficiaries for Par and Poke..., Fla., Dec. 1 The Joyn... of Tampa Bay, Inc. and the Judeo Christian Health...009 Par and Poker Celebrity Challenge for Charity ... , "It is only appropriate that events like thi...
(Date:12/1/2008)...sunlight-derived nutrient tied to increased cardio...thDay News) -- A lack of vitamin D, which is abso... boost the risk of heart attacks and strokes, new ...tudies linking increased cardiovascular risk with ... director of preventive cardiology at the Mid Amer...
(Date:12/1/2008)...c. 1, 2008 The Arthritis Foundation announces the...esearch in arthritis. The recipients, Dr. Gerard K...icians and Dr. Michel Nussenzweig of Rockefeller U...esearch advancements in the cure and control of rh...for his research in the development and function o...
Breaking Medicine News(10 mins):Health News:JCI online early table of contents: Dec. 1, 2008 2Health News:JCI online early table of contents: Dec. 1, 2008 3Health News:JCI online early table of contents: Dec. 1, 2008 4Health News:Celebrity Event Gives Local Non-Profits a Reason to be Thankful 2Health News:Vitamin D Vital for the Heart 2Health News:Vitamin D Vital for the Heart 3
...of hospital admissions running at double the numbe...health problems have reached an all time high//.De...9 per cent in the past five years, Government sour...Statistics figures compiled for the NHS, found tha...
...roblems have been reported by residents living nea...the years following the massive fire which ripped/...people reported common health problems such as ecz...egularities, However environment and health expert...
...ector general of health had stated on Friday that ...ercrowding had led to the Klebsiella// outbreak at...had killed 22 babies early in 2005. Thami Mseleku...ese problems. We are looking at a historical issue...
...motto to facilitate improvement in the area of men... garner acceptance from stakeholders //to petition...sh section of Amnesty International, Bodywhys, GRO...zophrenia Ireland are putting their heads together...
Other Medicine News:Health News:Alcohol-Related Illnesses On The Rise 2Health News:No Clue to Cause of Mystery Illnesses 2Health News:Klebsiella Outbreak In Durban Blamed On Staff Shortage & Overcrowding 2
...te methods to validate quantitation of patient sam...tip bottles for convenience and ease of use, elimi...alues are provided for analytes assayed on most ma...Aeroset, Labconco Chloridometer, Synchron, Dimensi...
This unassayed control is intended as a means of monitoring manual and automated assay methods used for the quantitation of oxalate in human urine samples. This control is ready-to-use liquid, requir
...nce for urinalysis quality control one bottle wit...uct for dipstick, hCG, and microscopics quality co... and microalbumin. Values are provided for microsc...litative results for hCG are also included. Dipand...
...e available in five protein concentrations: 12.5, ...L dropper bottles. They are liquid, ready-to-use, ...rmulated in an aqueos matrix using purified human ...in to 30% globulin. Stabilizers and preservatives,...
Medicine Products: